Large gap with delayed quotes
|
Last quote
02/28/2026
-
02:00:00
|
Bid
02/27/2026 -
21:59:58
|
Bid Volume |
Ask
02/27/2026 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
7.61
-0.165
(
-2.12% )
|
7.60
|
1,300 |
7.65
|
900 |
Analysis date: 24.02.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 10.02.2026.
Interest
None
None
No stars since 10.02.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 10.02.2026 at a price of 8.62.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 03.02.2026.
4wk Rel Perf
-12.88%
-12.88%
The four-week dividend-adjusted underperformance versus TSX Composite is 12.88%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 03.10.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.42%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.79%.
Mkt Cap in $bn
0.26
0.26
With a market capitalization <$2bn, PROFOUND MEDICAL is considered a small-cap stock.
G/PE Ratio
0.95
0.95
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
-12.07
-12.07
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
11.47%
11.47%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
80
80
For 1% of index variation, the stock varies on average by 0.80%.
Correlation
0.19
0.19
Stock movements are totally independent of index variations.
Value at Risk
5
5
The value at risk is estimated at CAD 5.00. The risk is therefore 51.77%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.10.2025
03.10.2025